GGrantIndex
← Search

HSV1 ONCOLYSIS-IMMUNE CHECKPOINT INHIBITION THERAPY FOR BREAST CANCER MENINGEAL METASTASES

$748,007FY2020Department of the ArmyDOD

The General Hospital Corporation

Investigators

View source on USAspending →
HSV1 ONCOLYSIS-IMMUNE CHECKPOINT INHIBITION THERAPY FOR BREAST CANCER MENINGEAL METASTASES · GrantIndex